Gapor, Jeanhyl L.

HRN: 26-59-47  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/06/2025
02/08/2025
IV
500 Mg
Q8
Bacterial Vaginosis Vs Vulvovagibal Candidiasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: